CAS RN: 161715-21-5
Tebipenem
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260206
100mg / 250mg / 1g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 161715-21-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
161715-21-5 / (4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Standard CAS: 161715-21-5
Multi CAS: No
Basic Information
copy
CAS
161715-21-5 copy
Multi CAS
No copy
Molecular Formula
C16H21N3O4S2 copy
Molecular Weight
383.500000 copy
Exact Mass
383.097349 copy
SMILES
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O copy
InChI
InChI=1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1 copy
InChIKey
GXXLUDOKHXEFBQ-YJFSRANCSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
25 copy
Fraction Csp3
0.69 copy
Rotatable bonds
4 copy
H-bond acceptors
7 copy
H-bond donors
2 copy
Molar refractivity
97.34 copy
TPSA
93.44 copy
LogP / Solubility
WLOGP
0.66 copy
MLOGP
0.6 copy
XLogP3
0.6 copy
Consensus LogP
0.62 copy
Log S (ESOL)
-2.37 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.18 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.18 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.59 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy